Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Diagnamed HoldingsDGNMF Equity-to-Asset is -0.54 as of Jun. 2026. The stock has 1 warning sign investors should review. Among 687 Healthcare Providers & Services companies, Diagnamed Holdings ranks worse than 94.32% on this metric.
The historical rank and industry rank for Diagnamed Holdings's Equity-to-Asset or its related term are showing as below:
DGNMF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -3.8 Med: -0.22 Max: 0.94
Current: -0.54
During the past 5 years, the highest Equity to Asset Ratio of Diagnamed Holdings was 0.94. The lowest was -3.80. And the median was -0.22.
DGNMF's Equity-to-Asset is ranked worse than 94.32% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs DGNMF: -0.54
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Diagnamed Holdings Equity-to-Asset Related Terms
Diagnamed Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Diagnamed Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DGNMF vs VEEV, BTSG, HQY: Equity-to-Asset Comparison
For the Health Information Services subindustry, Diagnamed Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnamed Holdings Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Diagnamed Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Diagnamed Holdings's Equity to Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnamed Holdings (DGNMF) has a Equity-to-Asset of -0.54 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Diagnamed Holdings and its competitors. According to the industry distribution chart, Diagnamed Holdings ranks #648 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 94.3%.
Is Diagnamed Holdings' Equity-to-Asset too high?
Diagnamed Holdings' current Equity-to-Asset is -0.54. Based on the distribution chart, Diagnamed Holdings ranks #648 out of 687 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Diagnamed Holdings' Equity-to-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diagnamed Holdings ranks #648 out of 687 companies for Equity-to-Asset. This places Diagnamed Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Diagnamed Holdings and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnamed Holdings's current Equity-to-Asset is -0.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (DGNMF) has a current Equity-to-Asset of -0.54. The current Equity-to-Asset is -0.54. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Diagnamed Holdings (DGNMF), the current Equity-to-Asset is -0.54 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DGNMF has been successfully added to your 
